Back to results
US 2014/0179636 A1Published application
Liquid formulations
AssigneeNovartis AG
InventorsVivian Georgousis, Wei-Qin Tong
Life of this patent
Estimating the term…
Abstract
Disclosed is a concentrate for dilution comprising a S1P receptor agonist or a pharmaceutically acceptable salt thereof, propylene glycol and optionally glycerin. This formulation is adapted for patients in a difficult condition to swallow.
Claims9
A concentrate for dilution comprising a S1P receptor modulator or agonist or a pharmaceutically acceptable salt thereof, and propylene glycol.
Dependencies are inferred from the claim text.